Skip to main content
. 2023 Feb 2;14:1113932. doi: 10.3389/fimmu.2023.1113932

Figure 2.

Figure 2

Severe COVID-19 patients have more CD4+ CD62L+ Tregs. The frequencies of CD4+ and CD8+ Tregs (viable, CD14- CD56-, CD19-, CD3+, CD4+ or CD8+, CD127lo, CD25+ FoxP3+) in non-severe and severe COVID-19 patients, recovered COVID-19 patients, and healthy controls were assessed by flow cytometry. (A) Example flow cytometry staining showing CD4+ CD62L+ T cells being gated on CD127lo, followed by gating for CD25+ FoxP3+ to identify Tregs. (B) CD4+ CD62L+ Tregs; (C) CD8+ CD62L+ Tregs. *p<0.05 one way ANOVA with multiple comparisons correction.